(Postgrad Med[TA])
15,941 results
  • Real-world comparison of jak inhibitors and TNF inhibitor cycling in axial spondyloarthritis patients after TNFi failure. [Journal Article]
    Postgrad Med. 2026 Oct 22; :1-7. [Online ahead of print]Kaya MN, Tecer D, … Yılmaz SPM
  • CONCLUSIONS: Following prior TNFi failure, TNFi cycling was associated with longer observed drug survival compared with JAKi therapy. However, given the retrospective design and differences in prior treatment exposure, this finding should be interpreted as a descriptive real-world observation rather than definitive evidence of comparative effectiveness. JAK inhibitors may still represent a viable option for selected refractory patients with multiple prior TNFi failures.
  • Sweet syndrome and thyroid diseases: a case-based review of a possible association. [Review]
    Postgrad Med. 2026 Oct 07; :1-6. [Online ahead of print]Rashid S, Gulati N, van Gerwen MPM
  • Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare dermatological condition characterized by the abrupt onset of tender, erythematous skin lesions, often presenting with fever and systemic inflammation. It is commonly associated with infection, malignancy, and medication exposure. Isolated case reports have described the co-occurrence of Sweet syndrome and thyroid dise…
  • Respiratory depression with concomitant use of opioids and cannabinoids: a case report. [Journal Article]
    Postgrad Med. 2026 Oct 01; :1-4. [Online ahead of print]Messick CL, Svendsen M, … Rejbi MPM
  • CONCLUSIONS: In our case, we describe how 100 mg cannabinoid product was a contributing factor in acute opioid toxicity possibly due to active inhibition of UGT2B7 (UDP-glucuronosyltransferase 2B7), a liver enzyme crucial in the metabolism of morphine. For patients who use cannabis, explicit counseling regarding the risks of combining high-dose opioids with high-dose cannabinoids is needed. Proactive counseling with patients in this changing landscape of cannabinoid use will become essential for their safety in the treatment of cancer-related pain.
  • Diabetes and skin health: a statewide survey on Ohio healthcare providers' knowledge. [Journal Article]
    Postgrad Med. 2026 Oct 01; :1-7. [Online ahead of print]Beach SC, Healy AM, Hughes ASPM
  • CONCLUSIONS: These findings suggest potential knowledge gaps on the topic, which warrants further evaluation of the quality of diabetes care and patient outcomes. These results may help inform educational efforts for HCPs to enhance overall knowledge of dermatologic manifestations of diabetes. Further studies should assess knowledge and practice patterns among primary care healthcare professionals.